A rare acid-promoted elimination of O-methyl oximes: A practical synthesis of 3-cyano-4-benzopyrones

Journal of Organic Chemistry

Volumn 64, Issue 23, 1999, Pages 8736-8740

  Hsung, Richard P ^a   Zificsak, Craig A ^a   Wei, Lin Li ^a   Zehnder, Luke R ^a   Park, Francis ^a   Kim, Michelle ^a   Tran, Thuy Trang T ^a  

^a University of Minnesota   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 CYANO 4 BENZOPYRONE; 6 ISOPROPYL 4 OXO 4H 1 BENZOPYRAN 3 CARBOXALDEHYDE 3 O METHYL OXIME; PYRONE DERIVATIVE; UNCLASSIFIED DRUG; XANTHONE DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; CONFORMATIONAL TRANSITION; DRUG CONFORMATION; DRUG SYNTHESIS; STRUCTURE ACTIVITY RELATION;

EID: 0033550224     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo991031j     Document Type: Article

References (52)

1. For a recent review see: (a) Ghosh, C. K.; Ghosh, C. Indian J. Chem. 1997, 968. For the first example of 3-acyl-4-pyrones functioning as dienophiles see: (b) Groundwater, P. W.; Hibbs, D. E.; Hursthouse, M. B.; Nyerges, M. J. Chem. Soc., Perkin Trans. 1 1997, 163.
2. For a recent review see: (a) Ghosh, C. K.; Ghosh, C. Indian J. Chem. 1997, 968. For the first example of 3-acyl-4-pyrones functioning as dienophiles see: (b) Groundwater, P. W.; Hibbs, D. E.; Hursthouse, M. B.; Nyerges, M. J. Chem. Soc., Perkin Trans. 1 1997, 163.
3. For a recent elegant study on 3-acyl- and 3-cyano-4-pyrones functioning as dienophiles see: Chen, D.; Wang, J.; Totah, N. I. J. Org. Chem. 1999, 64, 1776.
4. For studies on 3-nitrile-4-benzopyrones functioning as dienophiles see: (a) Hsung, R. P. J. Org. Chem. 1997, 62, 7904. (b) Hsung, R. P. Heterocycles 1998, 48, 421. (c) Granum, K. G.; Merkel, G.; Mulder, J. A.; Debbins, S. A.; Hsung, R. P. Tetrahedron Lett. 1998, 9597.
5. For studies on 3-nitrile-4-benzopyrones functioning as dienophiles see: (a) Hsung, R. P. J. Org. Chem. 1997, 62, 7904. (b) Hsung, R. P. Heterocycles 1998, 48, 421. (c) Granum, K. G.; Merkel, G.; Mulder, J. A.; Debbins, S. A.; Hsung, R. P. Tetrahedron Lett. 1998, 9597.
6. For studies on 3-nitrile-4-benzopyrones functioning as dienophiles see: (a) Hsung, R. P. J. Org. Chem. 1997, 62, 7904. (b) Hsung, R. P. Heterocycles 1998, 48, 421. (c) Granum, K. G.; Merkel, G.; Mulder, J. A.; Debbins, S. A.; Hsung, R. P. Tetrahedron Lett. 1998, 9597.
7. For the only other examples of benzopyrones functioning as dienophiles see: (a) Cremins, P. J.; Saengchantara, S. T.; Wallace, T. W. Tetrahedron 1987, 13, 3075. (b) Ohkata, K.; Kubo, T.; Miyamoto, K.; Ono, M.; Yamamoto, J.; Akiba, K. Heterocycles 1994, 38, 1483.
8. For the only other examples of benzopyrones functioning as dienophiles see: (a) Cremins, P. J.; Saengchantara, S. T.; Wallace, T. W. Tetrahedron 1987, 13, 3075. (b) Ohkata, K.; Kubo, T.; Miyamoto, K.; Ono, M.; Yamamoto, J.; Akiba, K. Heterocycles 1994, 38, 1483.
9. Arisugacin has been found to be a potent and selective inhibitor of acetylcholinesterase. For a leading reference see: Otoguro, K.; Kuno, F.; Ömura, S. Pharmacol. Ther. 1997, 76, 45.
10. For studies related to arisugacin see: (a) Obata, R.; Sunazuka, T.; Tian, Z.; Tomoda, H.; Harigaya, Y.; Ömura, S.; Smith, A. B. III. Chem. Lett. 1997, 935. (b) Hua, D. H.; Chen, Y.; Sin, H.-S.; Maroto, M. J.; Robinson, P. D.; Newell, S. W.; Perchellet, E. M.; Ladesich, J. B.; Freeman, J. A.; Perchellet, J.-P.; Chiang, P. K. J. Org. Chem. 1997, 62, 6888.
11. For studies related to arisugacin see: (a) Obata, R.; Sunazuka, T.; Tian, Z.; Tomoda, H.; Harigaya, Y.; Ömura, S.; Smith, A. B. III. Chem. Lett. 1997, 935. (b) Hua, D. H.; Chen, Y.; Sin, H.-S.; Maroto, M. J.; Robinson, P. D.; Newell, S. W.; Perchellet, E. M.; Ladesich, J. B.; Freeman, J. A.; Perchellet, J.-P.; Chiang, P. K. J. Org. Chem. 1997, 62, 6888.
12. For our other related efforts see: (a) Hsung, R. P.; Shen, H. C.; Douglas, C. J.; Morgan, C. D.; Degen, S. J.; Yao, L. J. J. Org. Chem. 1999, 64, 690. (b) Hsung, R. P.; Wei, L.-L.; Sklenicka, H. M.; Douglas, C. J.; McLaughlin, M. J.; Mulder, J. A.; Yao, L. J. Org. Lett. 1999, 1, 509. (c) Wei, L.-L.; Xiong, H.; Douglas, C. J.; Hsung, R. P. Tetrahedron Lett. 1999, 6903. (d) Hsung, R. P.; Zificsak, C. A.; Wei, L.-L.; Douglas, C. J.; Xiong, H.; Mulder, J. A. Org. Lett. 1999, 1, 1237-1240. (e) Douglas, C. J.; Sklenicka, H. M.; Shen, H. C.; Mathias, D. S.; Golding, G. M.; Hsung, R. P.; Degen, S. J.; Morgan, C. D.; Mueller, K. L.; Seurer, L. M.; Shih, R. A. Tetrahedron 1999, 55, in press.
13. For our other related efforts see: (a) Hsung, R. P.; Shen, H. C.; Douglas, C. J.; Morgan, C. D.; Degen, S. J.; Yao, L. J. J. Org. Chem. 1999, 64, 690. (b) Hsung, R. P.; Wei, L.-L.; Sklenicka, H. M.; Douglas, C. J.; McLaughlin, M. J.; Mulder, J. A.; Yao, L. J. Org. Lett. 1999, 1, 509. (c) Wei, L.-L.; Xiong, H.; Douglas, C. J.; Hsung, R. P. Tetrahedron Lett. 1999, 6903. (d) Hsung, R. P.; Zificsak, C. A.; Wei, L.-L.; Douglas, C. J.; Xiong, H.; Mulder, J. A. Org. Lett. 1999, 1, 1237-1240. (e) Douglas, C. J.; Sklenicka, H. M.; Shen, H. C.; Mathias, D. S.; Golding, G. M.; Hsung, R. P.; Degen, S. J.; Morgan, C. D.; Mueller, K. L.; Seurer, L. M.; Shih, R. A. Tetrahedron 1999, 55, in press.
14. For our other related efforts see: (a) Hsung, R. P.; Shen, H. C.; Douglas, C. J.; Morgan, C. D.; Degen, S. J.; Yao, L. J. J. Org. Chem. 1999, 64, 690. (b) Hsung, R. P.; Wei, L.-L.; Sklenicka, H. M.; Douglas, C. J.; McLaughlin, M. J.; Mulder, J. A.; Yao, L. J. Org. Lett. 1999, 1, 509. (c) Wei, L.-L.; Xiong, H.; Douglas, C. J.; Hsung, R. P. Tetrahedron Lett. 1999, 6903. (d) Hsung, R. P.; Zificsak, C. A.; Wei, L.-L.; Douglas, C. J.; Xiong, H.; Mulder, J. A. Org. Lett. 1999, 1, 1237-1240. (e) Douglas, C. J.; Sklenicka, H. M.; Shen, H. C.; Mathias, D. S.; Golding, G. M.; Hsung, R. P.; Degen, S. J.; Morgan, C. D.; Mueller, K. L.; Seurer, L. M.; Shih, R. A. Tetrahedron 1999, 55, in press.
15. For our other related efforts see: (a) Hsung, R. P.; Shen, H. C.; Douglas, C. J.; Morgan, C. D.; Degen, S. J.; Yao, L. J. J. Org. Chem. 1999, 64, 690. (b) Hsung, R. P.; Wei, L.-L.; Sklenicka, H. M.; Douglas, C. J.; McLaughlin, M. J.; Mulder, J. A.; Yao, L. J. Org. Lett. 1999, 1, 509. (c) Wei, L.-L.; Xiong, H.; Douglas, C. J.; Hsung, R. P. Tetrahedron Lett. 1999, 6903. (d) Hsung, R. P.; Zificsak, C. A.; Wei, L.-L.; Douglas, C. J.; Xiong, H.; Mulder, J. A. Org. Lett. 1999, 1, 1237-1240. (e) Douglas, C. J.; Sklenicka, H. M.; Shen, H. C.; Mathias, D. S.; Golding, G. M.; Hsung, R. P.; Degen, S. J.; Morgan, C. D.; Mueller, K. L.; Seurer, L. M.; Shih, R. A. Tetrahedron 1999, 55, in press.
16. For our other related efforts see: (a) Hsung, R. P.; Shen, H. C.; Douglas, C. J.; Morgan, C. D.; Degen, S. J.; Yao, L. J. J. Org. Chem. 1999, 64, 690. (b) Hsung, R. P.; Wei, L.-L.; Sklenicka, H. M.; Douglas, C. J.; McLaughlin, M. J.; Mulder, J. A.; Yao, L. J. Org. Lett. 1999, 1, 509. (c) Wei, L.-L.; Xiong, H.; Douglas, C. J.; Hsung, R. P. Tetrahedron Lett. 1999, 6903. (d) Hsung, R. P.; Zificsak, C. A.; Wei, L.-L.; Douglas, C. J.; Xiong, H.; Mulder, J. A. Org. Lett. 1999, 1, 1237-1240. (e) Douglas, C. J.; Sklenicka, H. M.; Shen, H. C.; Mathias, D. S.; Golding, G. M.; Hsung, R. P.; Degen, S. J.; Morgan, C. D.; Mueller, K. L.; Seurer, L. M.; Shih, R. A. Tetrahedron 1999, 55, in press.
17. For leading references see: (a) Obata, R.; Sunazuka, T.; Li, Z. R.; Tian, Z. M.; Harigava, Y.; Tabata, N.; Tomoda, H.; Ömura, S. J. Antibiot. 1996, 49, 1133. (b) Smith, A. B., III; Kinsho, T.; Sunazuka, T.; Ömura, S. Tetrahedron Lett. 1996, 6461. (c) Nagamitsu, T.; Sunazuka, T.; Obata, R.; Tomoda, H.; Tanaka, H.; Harigaya, Y.; Ömura, S.; Smith, A. B., III. J. Org. Chem. 1995, 60, 8126. (d) Parker, K. A.; Resnick, L. J. Org. Chem. 1995, 60, 5726.
18. For leading references see: (a) Obata, R.; Sunazuka, T.; Li, Z. R.; Tian, Z. M.; Harigava, Y.; Tabata, N.; Tomoda, H.; Ömura, S. J. Antibiot. 1996, 49, 1133. (b) Smith, A. B., III; Kinsho, T.; Sunazuka, T.; Ömura, S. Tetrahedron Lett. 1996, 6461. (c) Nagamitsu, T.; Sunazuka, T.; Obata, R.; Tomoda, H.; Tanaka, H.; Harigaya, Y.; Ömura, S.; Smith, A. B., III. J. Org. Chem. 1995, 60, 8126. (d) Parker, K. A.; Resnick, L. J. Org. Chem. 1995, 60, 5726.
19. For leading references see: (a) Obata, R.; Sunazuka, T.; Li, Z. R.; Tian, Z. M.; Harigava, Y.; Tabata, N.; Tomoda, H.; Ömura, S. J. Antibiot. 1996, 49, 1133. (b) Smith, A. B., III; Kinsho, T.; Sunazuka, T.; Ömura, S. Tetrahedron Lett. 1996, 6461. (c) Nagamitsu, T.; Sunazuka, T.; Obata, R.; Tomoda, H.; Tanaka, H.; Harigaya, Y.; Ömura, S.; Smith, A. B., III. J. Org. Chem. 1995, 60, 8126. (d) Parker, K. A.; Resnick, L. J. Org. Chem. 1995, 60, 5726.
20. For leading references see: (a) Obata, R.; Sunazuka, T.; Li, Z. R.; Tian, Z. M.; Harigava, Y.; Tabata, N.; Tomoda, H.; Ömura, S. J. Antibiot. 1996, 49, 1133. (b) Smith, A. B., III; Kinsho, T.; Sunazuka, T.; Ömura, S. Tetrahedron Lett. 1996, 6461. (c) Nagamitsu, T.; Sunazuka, T.; Obata, R.; Tomoda, H.; Tanaka, H.; Harigaya, Y.; Ömura, S.; Smith, A. B., III. J. Org. Chem. 1995, 60, 8126. (d) Parker, K. A.; Resnick, L. J. Org. Chem. 1995, 60, 5726.
21. For total syntheses of forskolin see: (a) Corey, E. J.; Jardine, P. D. S.; Rohloff, J. C. J. Am. Chem. Soc. 1988, 110, 3672. (b) Ziegler, F. E.; Jaynes, B. H.; Saindane, M. T. J. Am. Chem. Soc. 1987, 109, 8115.
22. For total syntheses of forskolin see: (a) Corey, E. J.; Jardine, P. D. S.; Rohloff, J. C. J. Am. Chem. Soc. 1988, 110, 3672. (b) Ziegler, F. E.; Jaynes, B. H.; Saindane, M. T. J. Am. Chem. Soc. 1987, 109, 8115.
23. Degen, S. J.; Mueller, K. L.; Shen, H. C.; Mulder, J. A.; Golding, G. M.; Wei, L.-L.; Zificsak, C. A.; Hsung, R. P. Bioorg. Med. Chem. Lett. 1999, 973.
24. Summers, W. K.; Majovski, L. V.; Marsh, G. M.; Tachiki, K.; Kling, A. N. Engl. J. Med. 1986, 315, 1241.
25. For some examples see: (a) Grinberg, L. N.; Newmark, H.; Kitrossky, N.; Rahamim, E.; Chevion, M.; Rachmilewitz, E. A. Biochem. Pharmacol. 1997, 54, 973. (b) Leanderson, P.; Faresjö, A. O.; Tagesson, C. Free Radical Biol. Med. 1997, 23, 235. (c) Agullo, G.; Payrastre, L. G.; Manenti, S.; Viala, C.; Résmésy, C.; Chap, H.; Payraste, B. Biochem. Pharmacol. 1997, 53, 1649. (d) Fotsis, T.; Pepper, M. S.; Aktas, E.; Breit, S.; Rasku, S.; Adlercreutz, H.; Wähälä, K.; Montesano, R.; Scheweigerer, L. Cancer Res. 1997, 57, 2916. (e) Wright, J. S.; Carpenter, D. J.; McKay, D. J.; Ingold, K. U. J. Am. Chem. Soc. 1997, 119, 4245.
26. For some examples see: (a) Grinberg, L. N.; Newmark, H.; Kitrossky, N.; Rahamim, E.; Chevion, M.; Rachmilewitz, E. A. Biochem. Pharmacol. 1997, 54, 973. (b) Leanderson, P.; Faresjö, A. O.; Tagesson, C. Free Radical Biol. Med. 1997, 23, 235. (c) Agullo, G.; Payrastre, L. G.; Manenti, S.; Viala, C.; Résmésy, C.; Chap, H.; Payraste, B. Biochem. Pharmacol. 1997, 53, 1649. (d) Fotsis, T.; Pepper, M. S.; Aktas, E.; Breit, S.; Rasku, S.; Adlercreutz, H.; Wähälä, K.; Montesano, R.; Scheweigerer, L. Cancer Res. 1997, 57, 2916. (e) Wright, J. S.; Carpenter, D. J.; McKay, D. J.; Ingold, K. U. J. Am. Chem. Soc. 1997, 119, 4245.
27. For some examples see: (a) Grinberg, L. N.; Newmark, H.; Kitrossky, N.; Rahamim, E.; Chevion, M.; Rachmilewitz, E. A. Biochem. Pharmacol. 1997, 54, 973. (b) Leanderson, P.; Faresjö, A. O.; Tagesson, C. Free Radical Biol. Med. 1997, 23, 235. (c) Agullo, G.; Payrastre, L. G.; Manenti, S.; Viala, C.; Résmésy, C.; Chap, H.; Payraste, B. Biochem. Pharmacol. 1997, 53, 1649. (d) Fotsis, T.; Pepper, M. S.; Aktas, E.; Breit, S.; Rasku, S.; Adlercreutz, H.; Wähälä, K.; Montesano, R.; Scheweigerer, L. Cancer Res. 1997, 57, 2916. (e) Wright, J. S.; Carpenter, D. J.; McKay, D. J.; Ingold, K. U. J. Am. Chem. Soc. 1997, 119, 4245.
28. For some examples see: (a) Grinberg, L. N.; Newmark, H.; Kitrossky, N.; Rahamim, E.; Chevion, M.; Rachmilewitz, E. A. Biochem. Pharmacol. 1997, 54, 973. (b) Leanderson, P.; Faresjö, A. O.; Tagesson, C. Free Radical Biol. Med. 1997, 23, 235. (c) Agullo, G.; Payrastre, L. G.; Manenti, S.; Viala, C.; Résmésy, C.; Chap, H.; Payraste, B. Biochem. Pharmacol. 1997, 53, 1649. (d) Fotsis, T.; Pepper, M. S.; Aktas, E.; Breit, S.; Rasku, S.; Adlercreutz, H.; Wähälä, K.; Montesano, R.; Scheweigerer, L. Cancer Res. 1997, 57, 2916. (e) Wright, J. S.; Carpenter, D. J.; McKay, D. J.; Ingold, K. U. J. Am. Chem. Soc. 1997, 119, 4245.
29. For some examples see: (a) Grinberg, L. N.; Newmark, H.; Kitrossky, N.; Rahamim, E.; Chevion, M.; Rachmilewitz, E. A. Biochem. Pharmacol. 1997, 54, 973. (b) Leanderson, P.; Faresjö, A. O.; Tagesson, C. Free Radical Biol. Med. 1997, 23, 235. (c) Agullo, G.; Payrastre, L. G.; Manenti, S.; Viala, C.; Résmésy, C.; Chap, H.; Payraste, B. Biochem. Pharmacol. 1997, 53, 1649. (d) Fotsis, T.; Pepper, M. S.; Aktas, E.; Breit, S.; Rasku, S.; Adlercreutz, H.; Wähälä, K.; Montesano, R.; Scheweigerer, L. Cancer Res. 1997, 57, 2916. (e) Wright, J. S.; Carpenter, D. J.; McKay, D. J.; Ingold, K. U. J. Am. Chem. Soc. 1997, 119, 4245.
30. (a) Mahmood, N.; Piacent, S.; Pizza, C.; Burke, A.; Khan, A. I.; Hay, A. J. Biochem. Biophys. Res. Commun. 1996, 229, 73.
31. (b) Li, B. Q.; Fu, T.; Yan, Y. D.; Baylor, N. W.; Ruscetti, F. W.; Kung, H. F. Cell. Mol. Biol. Res. 1993, 39, 119.
32. (a) Nohara, A. Tetrahedron Lett. 1974, 1187.
33. (b) Nohara, A.; Umetani, T.; Sanno, Y. Tetrahedron Lett. 1973, 1995.
34. (c) Goerlitzer, K.; Dehne, A. Arch. Pharm. (Weinheim, Ger.) 1984, 317, 448.
35. Both anhydrous and wet DMSO were used, but neither condition was fruitful.
36. For a review see: Falbe, J.; Bauer, W. In Methoden Der Organischen Chemie (Houben-Weyl); Erweiterungs-u. Folgebd. zur 4. Aufl., Bd.E5. Georg Thieme: Stuttgart, New York, 1985; pp 1322-1371.
37. (a) Mlochowski, J.; Giurg, M.; Uher, M.; Korenova, A.; Vegh, D. J. Prakt. Chem. 1996, 338, 65.
38. (b) Fernández, R.; Gasch, C.; Lassaletta, J.-M.; Liera, J.-M.; Vázquez, J. Tetrahedron Lett. 1993, 141.
39. (c) Díez, E.; Fernández, R.; Gasch, C.; Lassaletta, J.-M.; Liera, J.-M.; Martín-Zamora, E.; Vázquez, J. J. Org. Chem. 1997, 62, 5144.
40. Glover, E. E.; Rowbottom, K. T. J. Chem. Soc., Perkin Trans. 1 1976, 367.
41. 3-Bromo- or 3-iodo-4-benzopyrone was reacted with KCN, CuCN, or NaCN under a series of palladium-catalyzed coupling conditions, but the only discernible product has been the homo-coupling product. Regeuiro-Ren, A.; Zificsak, C. A.; Hsung, R. P. Unpublished results.
42. (a) Shiao, M.-J.; Shyu, L.-M.; Chen, C.-F. Heterocycles 1990, 31, 523.
43. (b) Anderson, B. A.; Bell, E. C.; Ginah, F. O.; Harn, N. K.; Pagh, L. M.; Wepsiec, J. P. J. Org. Chem. 1998, 63, 8224.
44. For examples of base-promoted elimination of O-methyl oximes see: (a) Hegarty, A. F.; Tuohey, P. J. J. Chem. Soc., Perkin Trans. 2 1980, 1313. (b) Itsuno, S.; Miyazaki, K.; Ito, K. Tetrahedron 1986, 27, 3033.
45. For examples of base-promoted elimination of O-methyl oximes see: (a) Hegarty, A. F.; Tuohey, P. J. J. Chem. Soc., Perkin Trans. 2 1980, 1313. (b) Itsuno, S.; Miyazaki, K.; Ito, K. Tetrahedron 1986, 27, 3033.
46. For examples of thermal elimination of O-methyl oximes see: (a) Hickson, C. L.; McNab, H. J. Chem. Soc. Perkin Trans. 1 1984, 1569. (b) Leardini, R.; Mcnab, H.; Nanni, D.; Parsons, S.; Reed, D.; Tenan, A. G. J. Chem. Soc., Perkin Trans. 1 1998, 1833.
47. For examples of thermal elimination of O-methyl oximes see: (a) Hickson, C. L.; McNab, H. J. Chem. Soc. Perkin Trans. 1 1984, 1569. (b) Leardini, R.; Mcnab, H.; Nanni, D.; Parsons, S.; Reed, D.; Tenan, A. G. J. Chem. Soc., Perkin Trans. 1 1998, 1833.
48. For an example of photochemically induced elimination of O-methyl oximes see: Pratt, A. C.; Abdul- Majid, Q. J. Chem. Soc., Perkin Trans. 1 1987, 359.
49. These O-methyl oximes were not very stable under basic conditions.
50. (a) Nohara, A.; Kuriki, H.; Saijo, T.; Sugihara, H.; Kanno, M.; Sanno, Y. J. Med. Chem. 1977, 20, 0, 141.
51. (b) Nohara, A.; Ishiguro, T.; Ukawa, K.; Sugihara, H.; Maki, Y.; Sanno, Y. J. Med. Chem. 1985, 20, 559.
52. Still, W. C.; Kahn, M.; Mitra, A. J. Org. Chem. 1878, 43, 2923.